secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oncotelic Therapeutics, Inc. (OTLC)
CIK:        0000908259
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001493152-25-028921
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncotelic launches PDAOAI platform and opens TGF-β corpus access
----------------------------------------------------------------

- Launched PDAOAI, an evidence-interrogation platform for extracting biological signals from large datasets without training custom LLMs.
- Providing open access to a TGF-β literature corpus of over 125,000 PubMed abstracts via a dedicated Discord research channel.
- Platform aims to enable researchers to analyze complex biomedical data without proprietary data training.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/908259/000149315225028921/0001493152-25-028921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/908259/000149315225028921/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer